Amesite Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2023. The filing is an annual report, not a standalone 2022 fourth-quarter report; it does not provide separate Q4 results.
Business context
Amesite develops and licenses a cloud-based, AI-enabled online learning platform and related content and services for universities, businesses, museums, K-12 organizations, and other institutions. Revenue comes primarily from platform licensing and associated services. The company reported one operating segment and 12 full-time employees and two consultants as of September 30, 2023.
Financial performance and position
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $845,009 | $697,001 |
| Operating expenses | $5,069,517 | $9,753,519 |
| Operating loss | $(4,224,508) | $(9,056,518) |
| Net loss | $(4,153,303) | $(9,059,923) |
| Operating cash used | $(3,249,176) | $(6,715,652) |
| Capital expenditures and software investment | $396,033 | $711,622 |
| Cash and cash equivalents at June 30 | $5,360,661 | $7,155,367 |
- Revenue increased about 21%, attributed primarily to annual licenses and implementation and customization services. Five customers represented approximately 84% of revenue in the MD&A; the financial-statement note reports approximately 87%, an inconsistency to verify. Three customers accounted for approximately 69% in FY2022.
- Revenue mix shifted: enterprise revenue was $513,969 versus $579,664; university revenue was $331,040 versus $97,337; K-12 revenue was zero versus $20,000.
- Net loss narrowed by approximately 54%, mainly as general and administrative, technology and content development, and sales and marketing expenses fell. The filing does not provide a separate gross-margin measure.
- Interest income was $72,824, compared with $9,230; interest expense was $1,619, compared with $12,635.
- Current assets were $5,482,340 and current liabilities were $265,327 at year-end. The balance sheet reports no long-term debt; cash included $157,500 held as a compensating balance and not readily available for general use.
- Shares outstanding were 2,542,440 at June 30, 2023, versus 2,166,124 a year earlier. The company completed a 1-for-12 reverse stock split in February 2023; share and per-share figures are retrospectively adjusted.
Changes, outlook, and risks
- Operating expenses declined substantially year over year, while revenue remained below $1 million. The company reported cumulative net losses of $33.4 million since incorporation and ongoing negative operating cash flows.
- The company raised approximately $1.85 million net in a September 2022 public offering and issued warrants to purchase 348,485 shares at $9.84 per share, plus underwriter warrants. It reported 521,038 warrants outstanding at June 30, 2023. The Lincoln Park purchase agreement expired August 2, 2023; no additional shares were sold under it during FY2023.
- Management stated that additional financing obtained after year-end and expense reductions alleviated the conditions that had raised substantial doubt about continuing as a going concern. The filing does not clearly quantify or detail that subsequent financing; elsewhere it says no material subsequent events were identified through October 6, 2023.
- No formal revenue or earnings guidance is provided. The company cautioned that it did not expect more than nominal revenue until at least some point in FY2024, and expects continued losses and cash use in the foreseeable future.
- Key risks include limited operating history and customer base, customer and revenue concentration, need for additional capital and potential dilution, intense competition, reliance on customers to drive enrollment, cybersecurity and privacy exposure, regulatory requirements, and Nasdaq listing compliance. The company reported it did not have cyber-risk insurance.
- The FY2023 financial statements received an unqualified audit opinion. Management said disclosure controls and internal control over financial reporting were effective and prior-year material weaknesses had been remediated. The auditor did not attest to internal control effectiveness, consistent with the company’s emerging-growth-company exemption.
Important facts for investors to verify
- Reconcile customer concentration: approximately 84% in MD&A versus approximately 87% in the financial-statement note.
- Review the amount, timing, terms, and source of the post-year-end financing cited in the going-concern discussion, and reconcile it with the subsequent-events disclosure.
- Assess cash runway against operating cash burn, including the restricted $157,500 cash balance and planned software-development spending.
- Evaluate customer retention, new contract wins, enrollment-linked fees, and progress in reducing reliance on a small number of customers.
- Assess potential dilution from outstanding warrants and equity financing needs, and verify continued compliance with Nasdaq listing requirements.